August 9, 2023 08:00 am ETEstimated Read Time: 6 Minutes
With its fascinating psychedelic properties, psilocybin therapy has gained considerable attention as a novel approach to mental health treatment, especially for those grappling with stubborn, hard-to-treat disorders.
Together, these institutions aimed to demystify the therapeutic pathways that cause a prolonged reduction in drinking problems in people with AUD following psilocybin therapy. To accomplish this, the researchers recruited volunteers who had participated in a prior psilocybin clinical trial. A series of in-depth questions were then asked to study participants about their experiences during and after the trial.
The Role of Psilocybin Therapy in Treating Alcohol Addiction
As the study delves deeper into the transformative effects of psilocybin therapy for AUD, several significant insights are revealed. For example:
Psilocybin therapy enhances interpersonal relationships, with participants noting improved self-compassion and awareness post-therapy, a sense of belonging, and stronger connections with others, highlighting its potential for overall emotional well-being beyond combating addiction.
The Participants and Their Relationship with Alcohol
Study participants were individuals entrenched in a grueling battle with alcohol, turning to it to manage stress. Many of them had relied on destructive coping mechanisms since childhood, a pattern that persisted into adulthood. Alcohol became their chosen tool to alleviate discomfort, distress, and social anxiety, offering a temporary reprieve from a torrent of adverse emotions.
However, their narratives revealed a disheartening pattern of excessive self-blame, guilt, and resentment. Participants also expressed an overwhelming tendency towards self-critical thought patterns, leading to constant intrusive thoughts. This relentless inner dialogue further exacerbated their emotional distress and fueled their reliance on alcohol. In essence, the relationship the participants shared with alcohol was complex, deeply ingrained, and marked by a grim cycle of emotional discomfort and alcohol-fueled escapism.
The Psilocybin Therapy Experience
The experiences described by the participants showed stark contrasts between the effects of alcohol and psilocybin. While alcohol provided temporary relief yet often fostered feelings of isolation and a lack of connection, psilocybin sparked a potent emotional awakening. This therapy opened the floodgates of suppressed emotions, with participants describing their experiences as an emotional rollercoaster, allowing for the release of deeply-held emotional pain associated with their alcohol use.
When confronted with these intense emotional upheavals, study participants highlighted the critical role of a controlled environment and the presence of therapists. It was vital to foster psychological safety in this therapeutic setting, to help them navigate their emotional landscapes, and to resolve the psychological obstacles that had blocked their progress for so long. Psilocybin served as more than a mere diversion from alcohol. It served as a healing journey guided by skilled therapists in a controlled environment.
Apply For Your Medical Marijuana Card Today
Veriheal has satisfied hundreds of thousands of patients nationwide
Get approved or your money back
Appointments available on-demand
Customer support available 24/7
Spiritual Insight and Mindfulness Techniques
The psilocybin experience led participants to deep spiritual insights, creating a profound shift in their worldviews and personal understanding. Alongside this spiritual reawakening, they discovered practical mindfulness techniques through psilocybin therapy. These tools helped them deal with overwhelming emotions, which they had previously drowned out with alcohol, demonstrating the therapeutic potential of psilocybin for substance abuse and overall mental well-being.
Study co-author and Fluence co-founder ,Elizabeth Nielson, eloquently captures the essence of the importance of qualitative research. She states, “Qualitative research gives us a direct understanding of the lived experience of psychedelic therapy clinical trial participants, from their perspective and in their own words.” This sentiment embodies the necessity of such research; it adds nuance, detail, and depth to our understanding, preparing future clinicians for the diverse experiences they may encounter in their work with patients undergoing psychedelic therapy.
Individual Differences and the Need for More Research
While psilocybin therapy has demonstrated encouraging new research results, it’s crucial to acknowledge that it isn’t a one-size-fits-all solution. Participants’ experiences varied, and despite significant improvements, the complete elimination of cravings wasn’t universal. As a result, this variation indicates the need for personalized therapeutic approaches, viewing psilocybin therapy as part of a broader treatment plan rather than a standalone solution. Additionally, this variation emphasizes the need for continued exploration into aspects like optimal dosage, therapeutic settings, supportive therapy techniques, and follow-up measures for psilocybin-assisted treatment.
The Role of Federal Agencies and Regulations Regarding Psilocybin Therapy
Federal agencies and regulatory bodies have become increasingly aware of the potential of psychedelics, like psilocybin, in addiction treatment. Institutions like the National Institute on Drug Abuse (NIDA) have initiated funding for research in this area, marking a critical step toward accepting previously stigmatized substances.
Meanwhile, advocates and lawmakers are leading legislative efforts to promote regulated access to these substances. Progress is evident in states like Oregon and Colorado, which are developing regulations for supervised and facilitated use of psilocybin and other psychedelics. This shift in societal perception and the evolving landscape of psychedelic regulation signal a significant evolution in the use of these substances for mental health therapy.
A Final Note
In conclusion, the transformative potential of psilocybin therapy for AUD is gaining recognition, as demonstrated by the findings of this study. It illustrates how psilocybin enables emotional processing, heightened self-awareness, and self-compassion, significantly reducing harmful drinking habits.
Yet, it’s crucial to remember that psilocybin is not a cure-all, but rather a promising therapeutic tool, necessitating further research into dosages, therapeutic settings, and aftercare.
Further, this study represents a significant milestone in psychedelic psychotherapy, supporting the need for further research. It has profound implications, hinting at a future where evidence-based treatments like psilocybin therapy are accessible to individuals grappling with AUDs and other mental health disorders.
Note: The content on this page is for informational purposes only and is not intended to be professional medical advice. Do not attempt to self-diagnose or prescribe treatment based on the information provided. Always consult a physician before making any decision on the treatment of a medical condition.
Lemetria Whitehurst is a cannabis nurse educator and writer specializing in cannabis science and culture. Her career in the medical industry spans more than two decades where she began her career as a pharmacy technician before becoming a registered nurse. As an avid reader
and researcher, she is passionate about educating others about cannabis’ medicinal properties.
Suddenly, the world of magic mushrooms is almost as complicated as that of learning about cannabis. Shrooms or “magic” mushrooms have gained traction as a hallucinogenic therapeutic application for several different mental health circumstances such as depression and migraines—particularly when microdosing. It’s not just liberty caps anymore, folks. There are many different varieties and types…
Edibles are arguably one of the best means of recreational cannabis consumption—you get to eat a treat AND experience a long-lasting high. But it’s easy to end up dealing with some unwanted side effects due to the variability in the onset of these THC-packed goodies, which come in the form of brownies, cookies, gummies, chocolate,…
If you’re reading this, you are either a recreational cannabis veteran who has seen a handful of cannabis smokers passing out from puffing a joint and can’t seem to figure out why. Or, you are a newbie who wants to give recreational or medical cannabis a shot, and the burning question on your mind is,…
When you decide that you are going to dabble in cannabis cultivation, you have many different decisions to make. You’ll have to decide whether you’re growing indoors or outdoors, as well as in soil, or the route of hydroponics. You’ll also have to pick what type of planters to use, what grow medium to use,…
A survey illustrates psychedelics’ rapid rise, Herer Brands sues Daniel Herer, and Hulkamania comes to cannabis. Let’s dive into this week’s canna-news. Psychedelic Use Reaches Record High A new national survey conducted by Monitoring The Future found that psychedelic use is at an all-time high amongst U.S. adults. Conducted in 2022, the survey included approximately…
The statements made regarding cannabis products on this website have not been evaluated by the Food and Drug Administration (FDA). Cannabis is not an FDA-approved substance and is still illegal under federal law. The information provided on this website is intended for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It is not intended as medical advice and should not be considered as a substitute for advice from a healthcare professional. We strongly recommend that you consult with a physician or other qualified healthcare provider before using any cannabis products. The use of any information provided on this website is solely at your own risk.